{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:14:36Z","timestamp":1789179276023,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"FEDER","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]},{"name":"FCT\u2014Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["FCOMP-01-0124-FEDER-022718 (PEst-C\/SAU\/LA0002\/2011)"],"award-info":[{"award-number":["FCOMP-01-0124-FEDER-022718 (PEst-C\/SAU\/LA0002\/2011)"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.gene.2013.11.073","type":"journal-article","created":{"date-parts":[[2013,12,13]],"date-time":"2013-12-13T12:50:50Z","timestamp":1386939050000},"page":"97-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Reduced glucosylceramide in the mouse model of Fabry disease: Correction by successful enzyme replacement therapy"],"prefix":"10.1016","volume":"536","author":[{"given":"Rui","family":"Quinta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Assun\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Fatima","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dami\u00e3o","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Clara","family":"S\u00e1 Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2013.11.073_bb0075","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2013.11.073_bb0080","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.cca.2010.07.038","article-title":"How well does urinary lyso-Gb3 function as a biomarker in Fabry disease?","volume":"411","author":"Auray-Blais","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.gene.2013.11.073_bb0265","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2141.2008.07380.x","article-title":"Anomalies in conventional T and invariant natural killer T-cell populations in Fabry mice but not in Fabry patients","volume":"143","author":"Balreira","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.gene.2013.11.073_bb0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-146-2-200701160-00148","article-title":"Agalsidase-beta therapy for advanced Fabry disease: a randomized trial","volume":"146","author":"Banikazemi","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.gene.2013.11.073_bb0065","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/187152506778520718","article-title":"The role of ceramide trihexoside (globotriaosylceramide) in the diagnosis and follow-up of the efficacy of treatment of Fabry disease: a review of the literature","volume":"4","author":"Bekri","year":"2006","journal-title":"Cardiovasc. Hematol. Agents Med. Chem."},{"key":"10.1016\/j.gene.2013.11.073_bb0165","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ymeth.2006.05.004","article-title":"Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography\u2013tandem mass spectrometry","volume":"39","author":"Bielawski","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.gene.2013.11.073_bb0195","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/(SICI)1098-1004(1996)8:1<38::AID-HUMU5>3.0.CO;2-L","article-title":"A sensitive mutation screening strategy for Fabry disease: detection of nine mutations in the alpha-galactosidase A gene","volume":"8","author":"Blanch","year":"1996","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.gene.2013.11.073_bb0260","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/ni.2143","article-title":"Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals","volume":"12","author":"Brennan","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.gene.2013.11.073_bb0285","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0076-6879(86)28063-5","article-title":"Comparative analysis of mammalian plasma lipoproteins","volume":"128","author":"Chapman","year":"1986","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.gene.2013.11.073_bb0280","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF02534789","article-title":"Distribution of antithrombin III and glucosylceramide in human plasma lipoproteins and lipoprotein deficient plasma","volume":"19","author":"Chatterjee","year":"1984","journal-title":"Lipids"},{"key":"10.1016\/j.gene.2013.11.073_bb0225","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(98)10034-X","article-title":"Broad screening test for sphingolipid-storage diseases","volume":"354","author":"Chen","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.gene.2013.11.073_bb0105","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ana.20870","article-title":"Gene therapy of the brain in the dog model of Hurler's syndrome","volume":"60","author":"Ciron","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.gene.2013.11.073_bb0110","doi-asserted-by":"crossref","first-page":"10229","DOI":"10.1523\/JNEUROSCI.3558-04.2004","article-title":"Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum","volume":"24","author":"Cressant","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.gene.2013.11.073_bb0145","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/BF02535529","article-title":"Stimulation of liver growth and DNA synthesis by glucosylceramide","volume":"23","author":"Datta","year":"1988","journal-title":"Lipids"},{"key":"10.1016\/j.gene.2013.11.073_bb0100","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ana.20150","article-title":"Prevention of neuropathology in the mouse model of Hurler syndrome","volume":"56","author":"Desmaris","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.gene.2013.11.073_bb0180","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1194\/jlr.M017178","article-title":"Sex differences of urinary and kidney globotriaosylceramide and lyso-globotriaosylceramide in Fabry mice","volume":"52","author":"Durant","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.gene.2013.11.073_bb0095","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ymgme.2007.03.001","article-title":"Bone marrow transplantation for feline mucopolysaccharidosis I","volume":"91","author":"Ellinwood","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.gene.2013.11.073_bb0190","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF03401671","article-title":"Fabry disease: thirty-five mutations in the alpha-galactosidase A gene in patients with classic and variant phenotypes","volume":"3","author":"Eng","year":"1997","journal-title":"Mol. Med."},{"key":"10.1016\/j.gene.2013.11.073_bb0115","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/mthe.2001.0274","article-title":"Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII","volume":"3","author":"Frisella","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.gene.2013.11.073_bb0245","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1476-511X-9-113","article-title":"Sphingolipids: the nexus between Gaucher disease and insulin resistance","volume":"9","author":"Fuller","year":"2010","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.gene.2013.11.073_bb0050","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1373\/clinchem.2004.041418","article-title":"Urinary lipid profiling for the identification of Fabry hemizygotes and heterozygotes","volume":"51","author":"Fuller","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.gene.2013.11.073_bb0215","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrm1423","article-title":"The cell biology of lysosomal storage disorders","volume":"5","author":"Futerman","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.gene.2013.11.073_bb0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.gene.2013.11.073_bb0120","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nm1073","article-title":"Niemann\u2013Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone","volume":"10","author":"Griffin","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.gene.2013.11.073_bb0170","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1194\/jlr.D008532","article-title":"Blood sphingolipidomics in healthy humans: impact of sample collection methodology","volume":"51","author":"Hammad","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.gene.2013.11.073_bb0135","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.gene.2013.11.073_bb0270","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1086\/316953","article-title":"Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice","volume":"68","author":"Ioannou","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.gene.2013.11.073_bb0250","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00280-012-1984-x","article-title":"Therapeutic potential of targeting ceramide\/glucosylceramide pathway in cancer","volume":"71","author":"Kartal Yandim","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.gene.2013.11.073_bb0275","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/glycob\/cwg034","article-title":"A biochemical and pharmacological comparison of enzyme replacement therapies for the glycolipid storage disorder Fabry disease","volume":"13","author":"Lee","year":"2003","journal-title":"Glycobiology"},{"key":"10.1016\/j.gene.2013.11.073_bb0160","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ymgme.2012.02.014","article-title":"Enzyme replacement therapy partially prevents invariant Natural Killer T cell deficiency in the Fabry disease mouse model","volume":"106","author":"Macedo","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.gene.2013.11.073_bb0155","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1172\/JCI117997","article-title":"Glucosylceramides stimulate murine epidermal hyperproliferation","volume":"95","author":"Marsh","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.gene.2013.11.073_bb0010","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.gene.2013.11.073_bb0230","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1042\/BJ20071043","article-title":"Effect of lysosomal storage on bis(monoacylglycero)phosphate","volume":"411","author":"Meikle","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.gene.2013.11.073_bb0200","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.jacc.2007.06.062","article-title":"Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy","volume":"50","author":"Monserrat","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.gene.2013.11.073_bb0175","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1194\/jlr.M009142","article-title":"Selective knockdown of ceramide synthases reveals complex interregulation of sphingolipid metabolism","volume":"52","author":"Mullen","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.gene.2013.11.073_bb0125","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.1073\/pnas.96.11.6423","article-title":"Aging accentuates and bone marrow transplantation ameliorates metabolic defects in Fabry disease mice","volume":"96","author":"Ohshima","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2013.11.073_bb0005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","article-title":"The frequency of lysosomal storage diseases in The Netherlands","volume":"105","author":"Poorthuis","year":"1999","journal-title":"Hum. Genet."},{"key":"10.1016\/j.gene.2013.11.073_bb0220","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1007\/s11064-010-0380-3","article-title":"Secondary alterations of sphingolipid metabolism in lysosomal storage diseases","volume":"36","author":"Prinetti","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.gene.2013.11.073_bb0130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nbd.2008.09.001","article-title":"Neurophysiological, behavioral and morphological abnormalities in the Fabry knockout mice","volume":"33","author":"Rodrigues","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.gene.2013.11.073_bb0085","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bbadis.2010.05.003","article-title":"Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry disease","volume":"1802","author":"Rombach","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.gene.2013.11.073_bb0045","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfi152","article-title":"Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting","volume":"21","author":"Schiffmann","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.gene.2013.11.073_bb0070","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/gim.2013.56","article-title":"Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1year of agalsidase alfa","volume":"15","author":"Schiffmann","year":"2013","journal-title":"Genet. Med."},{"key":"10.1016\/j.gene.2013.11.073_bb0185","doi-asserted-by":"crossref","first-page":"e2630","DOI":"10.1371\/journal.pone.0002630","article-title":"Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism\u2014the GENOBIN study","volume":"3","author":"Schwab","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2013.11.073_bb0205","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1479-7364-2-5-297","article-title":"Fabry disease: identification of 50 novel alpha-galactosidase A mutations causing the classic phenotype and three-dimensional structural analysis of 29 missense mutations","volume":"2","author":"Shabbeer","year":"2006","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.gene.2013.11.073_bb0150","doi-asserted-by":"crossref","first-page":"22968","DOI":"10.1016\/S0021-9258(18)54449-5","article-title":"Modulation of renal epithelial cell growth by glucosylceramide. Association with protein kinase C, sphingosine, and diacylglycerol","volume":"266","author":"Shayman","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2013.11.073_bb0235","doi-asserted-by":"crossref","first-page":"20960","DOI":"10.1074\/jbc.M702436200","article-title":"Caveolin-associated accumulation of globotriaosylceramide in the vascular endothelium of alpha-galactosidase A null mice","volume":"282","author":"Shu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2013.11.073_bb0240","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0962-8924(00)01847-X","article-title":"Jamming the endosomal system: lipid rafts and lysosomal storage diseases","volume":"10","author":"Simons","year":"2000","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.gene.2013.11.073_bb0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset Fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.gene.2013.11.073_bb0255","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1073\/pnas.0430327100","article-title":"Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by beta-d-glucosylceramide synthase deficiency","volume":"100","author":"Stanic","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2013.11.073_bb0055","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ymgme.2010.03.020","article-title":"Plasma globotriaosylsphingosine as a biomarker of Fabry disease","volume":"100","author":"Togawa","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.gene.2013.11.073_bb0210","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbadis.2010.09.007","article-title":"Reduction of elevated plasma globotriaosylsphingosine in patients with classic Fabry disease following enzyme replacement therapy","volume":"1812","author":"van Breemen","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.gene.2013.11.073_bb0290","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10545-006-0484-8","article-title":"The Dutch Fabry Cohort: diversity of clinical manifestations and Gb3 levels","volume":"30","author":"Vedder","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.gene.2013.11.073_bb0090","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbamcr.2008.11.014","article-title":"Secondary lipid accumulation in lysosomal disease","volume":"1793","author":"Walkley","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.gene.2013.11.073_bb0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/GIM.0b013e31802d8321","article-title":"Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life","volume":"9","author":"Wang","year":"2007","journal-title":"Genet. Med."},{"key":"10.1016\/j.gene.2013.11.073_bb0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10545-005-4415-x","article-title":"Monitoring enzyme replacement therapy in Fabry disease\u2014role of urine globotriaosylceramide","volume":"28","author":"Whitfield","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.gene.2013.11.073_bb0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/8904_2012_130","article-title":"Newborn screening for lysosomal storage disorders in Hungary","volume":"6","author":"Wittmann","year":"2012","journal-title":"JIMD Rep."},{"key":"10.1016\/j.gene.2013.11.073_bb0140","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.4049\/jimmunol.179.7.4829","article-title":"Aging up-regulates expression of inflammatory mediators in mouse adipose tissue","volume":"179","author":"Wu","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.gene.2013.11.073_bb0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/08035320510028111","article-title":"Is globotriaosylceramide a useful biomarker in Fabry disease?","volume":"94","author":"Young","year":"2005","journal-title":"Acta Paediatr. Suppl."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111913015990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111913015990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T13:31:52Z","timestamp":1716298312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111913015990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0378111913015990"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2013.11.073","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced glucosylceramide in the mouse model of Fabry disease: Correction by successful enzyme replacement therapy","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2013.11.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}